OBJECTIVES This prospective, observational study in 988 asymptomatic or symptomatic low-risk patients without prior coronary artery disease was conducted to define the relative value of coronary artery calcium score (CACS), exercise treadmill testing (ETT), and stress myocardial perfusion single-photon emission computed tomography (SPECT) variables in predicting long-term risk stratification.
T he coronary artery calcium score (CACS) severity has been reported to predict patients' cardiac outcomes (1, 2) , and CACS is considered an appropriate test in asymptomatic patients at intermediate to high clinical risk for coronary artery disease (CAD) (3, 4) . Likewise, exercise treadmill testing (ETT), performed with or without cardiac imaging, identifies those at high or low risk for mortality on the basis of the presence of stress-induced ischemia (5) , peak exercise capacity (in metabolic equivalents of task [METs] ) (6, 7) , and Duke treadmill score (DTS) (7, 8) . Current guidelines (3, 9) and appropriate use criteria (4) support both ETT and stress myocardial perfusion single-photon emission computed tomography (SPECT) for evaluating risk in selected asymptomatic patients with risk factors for CAD. However, there are no studies addressing which of these tests offer the most benefit in CAD detection and long-term risk stratification.
The purpose of this study was to examine the relative value of CACS, ETT, and SPECT in predicting long-term risk stratification in a large cohort of generally asymptomatic patients who had all tests performed within a close temporal period and who were followed up for up to a decade.
METHODS STUDY POPULATION.
This substudy analyzed data from a previously published prospective, observational follow-up trial in 1,175 predominantly middleaged (40 to 65 years) men and women who had both CACS and stress SPECT performed for clinically indicated reasons (10) . All patients had risk factors for, but no history of, CAD. The substudy included 988 patients (84%) who were stressed with ETT during SPECT (10) .
CACS was performed as the first-line test in 84% and SPECT in 16% of patients who were either asymptomatic (71% and 13%, respectively) or who had atypical chest pain (13% and 3%, respectively). No one had coronary revascularization performed between tests (median, 47 days), but 10 did so <60 days after testing.
The overall results did not differ with the inclusion or exclusion of these 10 patients, and no statistical interaction was observed between SPECT and ETT variables on patients' outcome (all, p > 0.20). Testing sequence also had no effect on outcome on univariate (8) . Risk on the basis of peak exercise capacity was classified as low (>8 METs), intermediate (5 to 8 METs), or high (<5 METs) (6).
SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY.
SPECT was performed according to standard guidelines (10) . Images were visually interpreted in all 3 standard projections, as previously reported, along with gated and raw image data to assess for study normalcy/abnormalcy and perfusion defect reversibility (10) .
CLINICAL ASSESSMENT AND PATIENT FOLLOW-UP.
Baseline demographic characteristics, symptom status, and medical history were prospectively recorded during interviews with experienced technical staff at the time of CACS testing. Patients were stratified, on the basis of standard FRS criteria, into categories of low (<6%), intermediate (6% to 20%), or high (>20%) 10-year risk for cardiac events (11).
Because absolute cholesterol and blood pressure measurements were not available, we calculated the FRS using conservative definitions of hyperlipidemia (cholesterol 200 to 239 mg/dl) and hypertension (systolic blood pressure 140 to 159 mm Hg) as previously reported (10).
Follow-up was prospectively performed using questionnaires, telephone interviews, and review of medical records (median follow-up: 6.9 years; 25th to 75th percentile: 4.7 to 8.8 years), with events corroborated as previously reported (10) . Cardiac events were defined as a composite of cardiac death, nonfatal myocardial infarction (MI), and the need for The p value for relative IDI was obtained using a permutation test. The NRI requires that there exist a priori meaningful risk categories (we used <6%, 6% to 20%, and >20% for the risk for cardiac events). Chang et al.
All analyses were performed with STATA version 12 (StataCorp LP, College Station, Texas). Statistical significance was defined as 2-tailed p < 0.05 for all tests.
The NRIs calculated with STATA may have been lower than if they had been calculated using SAS.
RESULTS
BASELINE CHARACTERISTICS. The mean age of the overall study population was 57.5 AE 9.3 years, and the median was 57 years (interquartile range: 51 to 64 years) ( Table 1) . Most of the patients (75.3%) were male, and 95% had 1 or more risk factors for CAD (68.2% had 2 or more risk factors). Nearly 10% of patients were diabetic, 43.0% had a family history of CAD, and 16.5% had atypical chest pain symptoms. Table 1) . Most patients with events had a CACS >100 (78.3%) or >400 (51.9%). All 10 patients (9.4%) with an event after a low-risk CACS also had a normal SPECT. Conversely, 22.6% and 26.4% of patients with events had ETT ischemia and/or an abnormal SPECT, respectively, which minimally increased to 29% and 34% in those with a CACS >400. Values are n (%).
Abbreviations as in Table 1 .
Chang et al. Table 4) . Similar findings were observed in the appropriate use cohort (Table 4) . When the models estimated cardiac death and/or MI, only decreasing DTS and increasing CACS severity added to the multivariate model ( Table 5 ).
In the appropriate use cohort, decreasing METs, decreasing DTS, and increasing CACS severity were the only multivariate predictors of the risk for cardiac death and/or MI ( Table 5) .
LONG-TERM CARDIAC EVENTS ON THE BASIS OF FRS, CACS, AND ETT RESULTS.
Cardiac event rates were significantly increased with increasing FRS category ( Figure 1A) , presence of ETT ischemia ( Figure 1B) , increasing CACS severity ( Figure 1C) Figure 1B) . CACS best 
<0.0001
Risk categories on the basis of 6% and 20% at a median follow-up of 6.9 years. IDI ¼ integrated discrimination improvement; NRI ¼ net reclassification improvement; rIDI ¼ relative IDI; other abbreviations as in Table 1 .
Chang et al. defined risk, with a very low AER of 0.62% in patients with a CACS #10 (0.59% if CACS ¼ 0), which was increased to 3.73% in those with a CACS >400
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( Figure 1C ).
LONG-TERM CARDIAC EVENTS IN LOW ETT/ SPECT RISK GROUPS ON THE BASIS OF CACS SEVERITY.
Event rates were compared across CACS severities within low-risk ETT and SPECT subgroups (Table 6, Figure 2 ). A CACS #10 defined a hazard ratio (HR) of 1.
In patients without ETT ischemia, AER was increased from 0.56% with CACS #10 to 3.15% with CACS >400 (p < 0.0001) (Figure 2A) , with an HR of 5.25 with CACS >400 ( Table 6 ). Time point analysis showed separation of event curves at year 4 after initial testing. The AER in the subgroup with a low-risk DTS was increased from 0.58% with CACS #10 to 3.00% with CACS >400 (p < 0.0001), with separation of event curves at year 5 ( Figure 2B ) and an HR of 5.13 with CACS >400 ( Table 6 ). The AER (95% CI) in the subgroup achieving >8 METs was increased from 0.52% (0.23% to 1.16%) with CACS #10, to 1.06% (0.60% to 1.86%) with CACS 11 to 100, to 1.15% (0.70% to 1.87%)
with CACS 101 to 400, to 3.41% (2.47% to 4.70%) with CACS >400 (p < 0.0001), with separation of event curves at year 3 (p ¼ 0.005) and an HR of 6.51 with CACS >400 (Table 6 ). In patients with a normal SPECT, HR was increased to 4.92 with CACS >400 (p < 0.0001) ( Table 6 ). The HR for any event also increased in the appropriate use cohort in the subgroup that had a CACS >400 (normal ETT: 5.17; lowrisk DTS: 4.85; >8 METs: 6.51; and normal SPECT:
4.12) ( Table 6 ). 
INCREMENTAL PROGNOSTIC VALUE OF CACS
DISCUSSION
We followed up a large-scale, generally asymptomatic cohort of men and women for up to a decade in order to assess the utility of CACS findings in MI ¼ myocardial infarction; other abbreviations as in Table 1 .
Chang et al. risk.
Our results demonstrate that CACS has incremental long-term prognostic value over and above the FRS and across all FRS categories. This finding was also observed in patients at low clinical risk who are currently not considered appropriate candidates for CACS testing. We also report relative superiority of CACS over all ETT and SPECT variables for identifying high-and low-risk subgroups and even among Event rates on the basis of Framingham risk score (A), exercise treadmill test (ETT) ischemia (B), and coronary artery calcium score (CACS) (C). Events were cardiac death, nonfatal myocardial infarction, and the need for coronary revascularization.
Chang et al.
patients in whom functional testing is currently considered appropriate. This finding was also true for the >80% of total patients who had low-risk ETT and SPECT findings. Our results reaffirm that functional testing is inappropriate in clinically low-risk patients but also demonstrate that CACS enhances risk prediction in those in whom functional testing is currently considered an appropriate initial strategy (11, 14) . We observed a significant increase in both global chi-square (from 11.7 to 45.3) and in AUC (from 0.63 to 0.70) when CACS was added to the FRS. Tables 1 and 4 .
Abbreviations as in
FIGURE 2 Long-Term Event Rates on the Basis of CACS Results in Low-Risk ETT Groups
Event rates on the basis of CACS results in patients without ETT ischemia (A) and low ($5) Duke treadmill score (DTS) (B). Events as in Figure 1 . Abbreviations as in Figure 1 .
Chang et al. Group (11) . In our study, CACS reclassified risk even among those considered at low annual risk despite a small sample size of 160 patients. The AER in the low FRS group was 0.97%. However, by adding CACS, the NRI in this group was more than 40%, with a 15-fold difference in event rates (0.37% with CACS #10 vs.
5.63% with CACS >400).
A low FRS was seen in 17% of our patients-consistent with the 22% prevalence in the Heinz Nixdorf trial (11) . In a recent study of 44,000 asymptomatic patients followed up for 5
years, CACS predicted all-cause mortality even among those with no significant CAD risk factors (15) .
Consistent with others, we also demonstrate the value of CACS in reclassifying risk in intermediate (NRI: 29%) and high (NRI: 35%) FRS groups (11, 14) . asymptomatic women demonstrated a significant reduction in total and cardiac mortality using the DTS, but exercise capacity primarily defined risk rather than symptoms or severity of ETT ischemia (7).
This finding may not be surprising because women have a wide variety of cardiac symptoms and frequent false-positive ETTs (9). Chang et al. SPECT FOR PREDICTING RISK. Stress SPECT identifies low-and high-risk asymptomatic patients, but an abnormal result is observed in a small minority of patients (17, 18) . We previously published that a normal SPECT has a short "warranty period" and limited long-term prognostic value compared with CACS (10). In the present study, SPECT was a predictor of total cardiac events ( However, this potential occurrence would be expected to have biased our study against observing a relationship between CACS and events. Third, although this was a single-center study, our cohort was similar to those of multicenter trials (1, 2, 11, 14) , and our follow-up time was considerably longer. 
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